This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Methyl dopa

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Methyl dopa is a centrally-acting antihypertensive drug that is gradually declining in usage. It inhibits decarboxylation of dopa to dopamine. Therapy is associated with reduced concentrations of dopamine, 5 - hydroxytryptamine and noradrenaline in peripheral tissues and the CNS. This drug is associated with a reduction in renin levels.

Indications for the use of methyl dopa include:

  • hypertension, in conjunction with a diuretic
  • hypertensive crisis when an immediate effect is not necessary

Cautions/Contraindications:

  • history of depression
  • active liver disease
  • porphyria
  • phaeochromocytoma
  • increases the CNS toxicity of lithium

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.